Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Sponsor and Collaborators
Duke University
Genentech
OSI Pharmaceuticals

Contact
David M Brizel, MD
919-668-5637
[email protected]

Clinical Trials
919-668-3726
[email protected]


Continue Reading

Principal Investigator
David M Brizel, MD
Department of Radiation Oncology; Duke University Medical Center

Clinical Trials.gov Identifier
NCT00140556